Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 7/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 7/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.34 |
| ▸ | ADK | P55263 | 1/20 | 0.34 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.34 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23914308 | 1.00 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3ESR1ESR2 | |
| SCHEMBL23914304 | 0.94 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3ESR1ESR2 | |
| SCHEMBL30528429 | 0.94 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3ESR1ESR2 | |
| SCHEMBL23914072 | 0.94 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3ESR1ESR2 | |
| SCHEMBL23914398 | 0.94 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3ESR1ESR2 | |
| SCHEMBL23913939 | 0.94 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3ESR1ESR2 | |
| SCHEMBL23914100 | 0.94 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3ESR1ESR2 | |
| SCHEMBL23914288 | 0.94 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3ESR1ESR2 | |
| SCHEMBL30528444 | 0.90 | CYP2A6 (0.41) | SLC6A2SLC6A4SLC6A3ESR1ESR2 | |
| SCHEMBL23913987 | 0.84 | ALDH1A1 (0.40) | SLC6A2SLC6A4SLC6A3ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | MIF, LTA, MGAM | SLC6A2 4850/4885SLC6A4 4444/4885SLC6A3 4632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.